Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SRSD107 in Healthy Subjects
NCT07655427Phase 1Completed
- Sponsor
- Sirius Therapeutics
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in thrombosis comparing SRSD107 with Placebo (2 arms). Primary endpoints: Proportion of adverse events and Proportion of Serious Adverse Events. Started Mar 2024; status: completed.
02
Drugs
SRSD107
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT07655427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07655427.